Reevaluation of Conventional Pituitary Irradiation in the Therapy of Acromegaly

被引：12

作者：

Jaffe C.A. ^{[1
,2
]}

机构：

[1] Department of Internal Medicine, Univ. of Michigan Medical Center, Ann Arbor Vet. Aff. Medical Center

[2] 3920 Taubman Center, Ann Arbor, MI 48109-0354

来源：

Pituitary | 1999年 / 2卷 / 1期

关键词：

Adenoma; Anterior pituitary; Growth hormone; Insulin-like growth factor I; Neoplasia;

D O I：

10.1023/A:1009969921497

中图分类号：

学科分类号：

摘要：

External beam pituitary irradiation has been frequently used in the treatment of growth hormone (GH) secreting pituitary adenomas. Many studies have demonstrated that serum GH declines rapidly and reliably following treatment and early "cure" rates, based on a basal serum GH below 10 μg/L were as high as 80%. The definition of "cure" has become more stringent over time and retrospective studies have indicated that GH must be below 2.5 μg/L for acromegalics to achieve mortality rates comparable to a normal population. Only 20% of irradiated patients will achieve this goal by 10 yr. Even fewer will achieve a normal serum insulin-like growth factor I (IGF-I) levels. Although pituitary irradiation still has a role in the control of tumor size, its importance as a treatment for normalizing serum GH is being reevaluated.

引用

页码：55 / 62

页数：7

共 64 条

[21]

Goffman T.E., Dewan R., Arakaki R., Gorden P., Oldfield E.H., Glatstein E., Persistent or recurrent acromegaly. Long-term endocrinologic efficacy and neurologic safety of postsurgical radiation therapy, Cancer, 69, pp. 271-275, (1992)

[22]

Speirs C.J., Reed P.I., Morrison R., Aber V., Joplin G.F., The effectiveness of external beam radiotherapy for acromegaly is not affected by previous pituitary ablative treatments, Acta Endocrinol (Copenh), 122, pp. 559-565, (1990)

[23]

Sheline G.F., Conventional radiation therapy in the treatment of pituitary tumors, Clinical Management of Pituitary Disorders, (1979)

[24]

Werner S., Af Trampe E., Palacios P., Lax I., Hall K., Growth hormone producing pituitary adenomas with concomitant hypersecretion of prolactin are particularly sensitive to photon irradiation, Int J Radiant Oncol Biol Phys, 11, pp. 1713-1720, (1985)

[25]

Wass J.A., Moult P.J., Thorner M.O., Dacie J.E., Charlesworth M., Jones A.E., Besser G.M., Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy, Lancet, 2, 8133, pp. 66-69, (1979)

[26]

Littley M.D., Shalet S.M., Swindell, Beardwell C.G., Sutton M.L., Low-dose pituitary irradiation for acromegaly, Clin Endocrinol, 32, pp. 261-270, (1990)

[27]

Baldwin A., Cundy T., Butler J., Et al., Progression of cardiovascular disease in acromegalic patients treated by external pituitary irradiation, Act Endocrinol (Copenh), 108, pp. 26-30, (1985)

[28]

Eastman R.C., Gorden P., Roth J., Conventional supervoltage irradiation is an effective treatment for acromegaly, J Clin Endocrinol Metab, 48, pp. 931-940, (1979)

[29]

Lombardi G., Colao A., Marzullo P., Ferone D., Longobardi S., Esposito V., Merola B., Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and of acromegaly, J Endocrinol, 155, (1997)

[30]

MacSweeney J.E., Baxter M.A., Joplin G.F., Heel pad thickness is an insensitive index of biochemical remission in acromegaly, Clin Radiol, 42, pp. 348-350, (1990)

← 1 2 3 4 5 6 7 →